Tang, Raymond S YRaymond S YTangSattayalertyanyong, OnumaOnumaSattayalertyanyongYU-TING KUOPark, Kenneth HKenneth HParkAnastassiades, ConstantinosConstantinosAnastassiadesLigresti, DarioDarioLigrestiHayashi, NobuhikoNobuhikoHayashiHasan, AwsAwsHasanKim, Tae-HyeonTae-HyeonKimPausawasdi, NonthaleeNonthaleePausawasdiHSIU-PO WANGLo, Simon KSimon KLoHo, Khek-YuKhek-YuHoBarresi, LucaLucaBarresiTraina, MarioMarioTrainaYasuda, IchiroIchiroYasudaSavides, Thomas JThomas JSavidesKoo, Chieh-SianChieh-SianKooChan, Ting TingTing TingChanLam, Thomas Y TThomas Y TLamSung, Joseph J YJoseph J YSung2023-02-242023-02-242022-12-290815-9319https://scholars.lib.ntu.edu.tw/handle/123456789/628779Dedicated studies evaluating the impact of COVID-19 on outcomes of pancreatobiliary IgG4 related disease (IgG4-RD) patients are scarce. Whether COVID-19 infection or vaccination would trigger IgG4-RD exacerbation remains unknown.enCOVID-19; COVID-19 vaccination; immunosuppressive therapy; pancreatobiliary IgG4 related disease[SDGs]SDG3journal article10.1111/jgh.16100365820402-s2.0-85146095831WOS:000908012000001https://api.elsevier.com/content/abstract/scopus_id/85146095831